MiaA is a key enzyme in the tRNA modification pathway, synthesizing the ms²i⁶A (2-methylthio-N⁶-isopentenyladenosine) modification. This modification:
Stabilizes tRNA structure, particularly in hypermodified residues near the anticodon loop .
Influences bacterial stress response systems, such as RpoS regulation in E. coli .
In C. fetus, MiaA’s role remains less characterized, but its conserved function across Campylobacter species suggests similar tRNA-modifying activity critical for virulence or environmental adaptation.
While no C. fetus subsp. fetus MiaA recombinant protein has been explicitly documented, homologs like Campylobacter curvus MiaA (UniProt: A7GW99) provide a structural and functional template :
| Property | Detail |
|---|---|
| Gene Source | Campylobacter curvus (strain 525.92) |
| Product Code | CSB-YP024529CWB |
| Purity | >85% (SDS-PAGE verified) |
| Storage | -20°C (short-term); -80°C (long-term) |
| Sequence Length | 294 amino acids |
| Key Domains | Prenyltransferase domain (residues 1–250) |
The enzyme’s amino acid sequence begins with MFCEFAIIGT... and includes conserved motifs for substrate binding and catalysis .
Studies in E. coli and Salmonella highlight MiaA’s pleiotropic effects:
RpoS Regulation: MiaA-deficient E. coli strains show 2–3-fold reduced RpoS protein levels, impairing stationary-phase survival and stress responses .
Antibiotic Sensitivity: Loss of tRNA modification in Campylobacter jejuni alters membrane permeability and efflux pump activity, increasing susceptibility to antibiotics like chloramphenicol and azithromycin .
These findings suggest that C. fetus MiaA could similarly influence virulence pathways or drug resistance, though direct evidence is lacking.
Key unanswered questions about C. fetus MiaA include:
Its role in host colonization or systemic infection.
Interactions with other tRNA modification enzymes (e.g., MiaB).
Impact on pathogenicity islands or secretion systems unique to C. fetus subsp. fetus .
Proteotyping and genomic tools developed for C. fetus subspecies differentiation (e.g., MLST, PCR-ribotyping) could be adapted to study MiaA’s expression patterns. Targeting tRNA modification pathways might offer novel strategies to disrupt C. fetus viability or virulence.
KEGG: cff:CFF8240_0216
MiaA (tRNA dimethylallyltransferase) catalyzes the first step of a two-step tRNA modification process in Campylobacter fetus. Specifically, MiaA, along with MiaB, facilitates the addition of the 2-methylthio-N6-(Δ2-isopentenyl), or ms2i6A, modification to adenine 37 of tRNAs that recognize codons beginning with uridine . This modification is crucial for translational fidelity and selective protein expression during bacterial responses to stress .
In C. fetus, MiaA plays a vital role in regulating gene expression through its effects on translation. Research has demonstrated that MiaA is necessary for the full expression of the stationary phase/general stress response sigma factor RpoS (σS). When miaA is mutated, RpoS expression decreases 2-3 fold, particularly upon entry into stationary phase (OD600 = 1.5 to 2.5) .
The miaA gene in C. fetus is located in a complex operon upstream of the gene for the RNA chaperone Hfq . Based on genomic analysis, the miaA gene is highly conserved across C. fetus subspecies. In C. fetus subsp. venerealis 97/608, the miaA gene (designated as CFV97608_0219) is annotated as tRNA(i6A37) synthase in the KEGG Orthology database (K00791) .
Complete genome sequencing has revealed that the miaA gene is present in both C. fetus subspecies: C. fetus subsp. fetus and C. fetus subsp. venerealis. Comparative genomic analysis shows that despite the distinct host and niche preferences of these two subspecies, they share a high level of genetic similarity, including conservation of the miaA gene .
Mutations in the miaA gene result in pleiotropic phenotypes in C. fetus, affecting multiple cellular processes . Key phenotypic changes include:
Decreased expression of RpoS (2-3 fold reduction), as demonstrated by both β-galactosidase assays and Western blot analysis
Altered translational fidelity, with significant increases in frameshifting in both +1 and -1 directions
Research has shown that the miaA mutation was the only tRNA modification mutation among those tested that resulted in a Lac- phenotype in an rpoS750-lacZ translational fusion strain, suggesting a specific role for MiaA in RpoS expression regulation .
Based on successful genetic tool development for C. fetus, the following methodology is recommended for cloning and expressing recombinant MiaA:
Vector Selection: E. coli-Campylobacter shuttle vectors based on the C. coli plasmid pIP1455 replicon have been successfully used for C. fetus . The pRY series vectors (e.g., pRY111) carrying a chloramphenicol acetyltransferase (cat) gene are suitable starting points.
Promoter Selection: For efficient expression in C. fetus, the C. fetus sapA promoter is critical. A 260-bp fragment homologous to the sapA promoter can be amplified by PCR and incorporated into the expression vector .
Cloning Strategy:
Amplify the miaA gene via PCR using C. fetus genomic DNA
Digest both the PCR product and vector with appropriate restriction enzymes
Ligate the digested products
Transform into E. coli DH5α for verification before transferring to C. fetus
Gene Transfer: Conjugative transfer from E. coli S17-1 λpir to C. fetus is more effective than electroporation, with typical transfer frequencies of ~10^-4 transconjugants per donor .
Expression Verification: Western blotting or enzymatic activity assays can confirm successful expression.
Construction of a pBAD-miaA plasmid has been documented in the literature, where the miaA gene was amplified via PCR using primers targeting the gene, followed by restriction enzyme digestion, and ligation into a digested pBAD24 vector .
Creating and characterizing miaA mutants in C. fetus requires specific approaches due to the unique characteristics of this organism:
Mutant Generation:
Verification Techniques:
PCR confirmation of the insertion
RNA extraction and reverse transcription qPCR to confirm lack of miaA expression
Complementation tests with plasmid-borne wild-type miaA to confirm phenotype specificity
Phenotypic Characterization:
β-galactosidase assays using rpoS-lacZ translational fusions
Western blot analysis of proteins affected by MiaA
Serum resistance assays
Invasion assays using epithelial cell lines
Animal models to assess virulence
Control Experiments:
The effects of miaA mutation can be measured using rpoS-lacZ translational fusion on MacConkey-lactose plates, where miaA::kan mutation results in a Lac- phenotype .
Several cell-based assays have proven effective for assessing MiaA's role in C. fetus virulence:
Gentamicin Protection (Invasion) Assays:
Methodology: Culture approximately 200,000 endometrial epithelial cells in a 25 cm² flask. Add bacteria (MOI 100:1 for C. fetus) diluted in DMEM and incubate for 2 hours at 37°C. Wash the monolayers three times with PBS and incubate with gentamicin to kill extracellular bacteria. Lyse cells and plate for viable counts or extract RNA for qPCR analysis .
This assay can be used to compare invasion efficiency between wild-type and miaA mutant strains.
Cytokine Expression Analysis:
Serum Resistance Assays:
Cytoskeleton Inhibition Assays:
Research has shown that C. fetus induces proinflammatory responses in bovine endometrial epithelial cells, with significant upregulation of IL-1β (4.62-fold increase) and IL-8 (3.62-fold increase) at 4 hours post-infection . Similar assays can be used to evaluate differences between wild-type and miaA mutant strains.
MiaA plays a crucial role in C. fetus stress adaptation through its effects on translational control:
Translational Fidelity Mechanism:
MiaA catalyzes the addition of the i6A modification to tRNAs, which affects codon-anticodon interactions.
Research in related bacteria shows that MiaA is critical for maintaining translational fidelity, particularly during stress responses .
MiaA-deficient strains show increased frameshifting in both +1 and -1 directions, affecting the accurate translation of stress-response proteins .
Regulatory Impact:
MiaA modulates the expression of RpoS, a master regulator of stress response genes.
In miaA mutants, RpoS expression decreases 2-3 fold, compromising the cell's ability to respond to various stressors .
This regulation appears to be at the translational level rather than through transcriptional control.
Dynamic Regulation:
Evidence suggests that bacteria can modulate MiaA levels in response to stress, providing a post-transcriptional mechanism to facilitate beneficial changes in their proteomes .
This represents a programmable mechanism that distressed cells can use to optimize their response to environmental challenges.
Experimental Evidence:
The regulatory role of MiaA extends beyond RpoS to potentially affect multiple stress response pathways, making it a key factor in C. fetus adaptation to the diverse environments it encounters during infection and transmission.
The relationship between MiaA activity and C. fetus host specificity represents an intriguing research area with several key aspects:
Subspecies-Specific Adaptation:
C. fetus comprises two main subspecies with distinct host preferences: C. fetus subsp. fetus (Cff) has a wider host range including humans and animals, while C. fetus subsp. venerealis (Cfv) is primarily adapted to the bovine genital tract .
Both subspecies possess the miaA gene, but its regulation and downstream effects may differ in ways that contribute to their distinct host tropisms.
Translational Control of Host-Specific Factors:
MiaA's role in translational control may influence the expression of host-specific virulence factors.
Different codon usage in host-specific genes could make their translation differentially dependent on MiaA-mediated tRNA modifications.
Interaction with Other Virulence Determinants:
MiaA likely works in concert with other host specificity determinants, such as:
Surface layer proteins (SLPs), which are critical for immune evasion and show variation between subspecies
Lipopolysaccharide (LPS) composition, which differs between sero-types A and B and affects host range
Type IV secretion systems (T4SS), which are differentially distributed among C. fetus strains and subspecies
Research Approaches:
Comparative analysis of miaA expression levels between subspecies during infection of different host cells
Identification of differentially translated proteins in miaA mutants using proteomic approaches
Cross-complementation studies between subspecies to determine if MiaA from one subspecies can fully restore function in a miaA mutant of the other subspecies
The table below summarizes key differences between C. fetus subspecies that may interact with MiaA function:
| Feature | C. fetus subsp. fetus | C. fetus subsp. venerealis | Potential Interaction with MiaA |
|---|---|---|---|
| Host range | Broad (humans, animals) | Narrow (bovine genital tract) | MiaA may affect translation of host-specific adaptation factors |
| Sero-types | Type A and B | Exclusively Type A | MiaA may influence expression of surface structures |
| LPS genes | Type A: glf+/mat1- Type B: glf-/mat1+/wcbK+ | mat1+/glf-/wcbK- | MiaA could affect translation of LPS biosynthesis genes |
| T4SS | Variable presence | Present in most strains | MiaA may regulate expression of secretion system components |
While direct evidence linking MiaA to host specificity in C. fetus is still emerging, its fundamental role in translational control suggests it likely contributes to the expression patterns that determine host adaptation.
The interaction between genomic islands (GIs), horizontal gene transfer (HGT) events, and MiaA function in C. fetus represents a complex relationship that affects bacterial adaptation and virulence:
The T4SS distribution in C. fetus strains, which may interact with MiaA function, is summarized in the following points based on research findings:
Three phylogenetically-different T4SS-encoding regions were identified in C. fetus genomes
Some T4SSs are located in both chromosomes and plasmids, while others are exclusively chromosomal or plasmid-based
The genomic islands containing T4SSs differ mainly by the presence of fic genes, insertion sequence elements, and phage-related or hypothetical proteins
T4SSs inserted in the same genomic locations were conserved across different C. fetus strains
Understanding how MiaA influences the expression and function of genes within these mobile genetic elements could provide insights into C. fetus evolution, adaptation, and pathogenesis.
To investigate the structural features of C. fetus MiaA and their relationship to function, researchers can employ several cutting-edge approaches:
Protein Structure Determination:
X-ray crystallography of purified recombinant MiaA to determine its three-dimensional structure
Cryo-electron microscopy (cryo-EM) as an alternative approach if crystallization proves challenging
Nuclear Magnetic Resonance (NMR) spectroscopy for analyzing dynamics and ligand interactions
Computational Structure Analysis:
Homology modeling based on known structures of MiaA from other bacteria
Molecular dynamics simulations to study substrate binding and catalytic mechanisms
Protein-substrate docking to identify key interaction residues
Structure-Function Analysis:
Site-directed mutagenesis of conserved residues identified through structural studies
Enzymatic assays to measure the effects of mutations on MiaA activity
Complementation studies in miaA knockout strains to correlate structural changes with in vivo function
Comparative Analysis:
Alignment of MiaA sequences from different Campylobacter species to identify conserved and variable regions
Comparison with MiaA enzymes from other bacterial genera to identify unique features of C. fetus MiaA
Analysis of coevolution between MiaA and its tRNA substrates
Experimental Protocol for Activity Assays:
Express and purify recombinant C. fetus MiaA with a His-tag
Prepare tRNA substrates either through in vitro transcription or extraction from cells
Conduct in vitro prenylation assays using dimethylallyl pyrophosphate (DMAPP) as the prenyl donor
Analyze reaction products using methods such as HPLC, mass spectrometry, or gel electrophoresis
Domain Analysis Protocol:
Identify functional domains through limited proteolysis and mass spectrometry
Create truncated variants to map minimal functional units
Perform domain swapping experiments with MiaA from other species to identify subspecies-specific functional elements
While specific structural studies on C. fetus MiaA have not been reported in the provided search results, the enzyme belongs to the tRNA dimethylallyltransferase family (EC:2.5.1.75) , for which structural information from related organisms could serve as a starting point for comparative analysis.
Understanding MiaA function in C. fetus could enhance diagnostic approaches in several ways:
Molecular Diagnostics:
While the miaA gene itself is conserved across C. fetus subspecies, its regulation and downstream effects may serve as subspecies-specific markers.
Diagnostic assays could target miaA expression patterns or MiaA-dependent translational products that differ between subspecies.
This could improve upon current diagnostic methods, as some established targets like the parA gene have been shown to be unreliable (detected in only 3 of 13 C. fetus subsp. venerealis isolates in one study) .
Biomarker Development:
Proteins whose translation is specifically regulated by MiaA could serve as biomarkers for C. fetus infection.
Proteomic analysis comparing wild-type and miaA mutant strains could identify such biomarkers.
These could be particularly valuable for diagnosing infections in immunocompromised patients, where C. fetus causes more severe disease .
Subspecies Differentiation:
C. fetus subspecies identification is clinically important as they cause different diseases:
MiaA-dependent translational profiles could potentially distinguish between these subspecies more accurately than current methods.
Clinical Relevance:
C. fetus infections should be suspected in patients with nonspecific febrile illness who are immunocompromised or occupationally exposed to ruminants .
Understanding MiaA's role in virulence could help identify high-risk patient populations.
In pregnant women, C. fetus infections can lead to abortion or neonatal sepsis, making accurate diagnosis critical .
Research Priorities:
Identifying MiaA-dependent proteins that are expressed during human infection
Developing antibody-based or nucleic acid tests targeting these proteins
Validating these approaches in clinical samples from both intestinal and systemic C. fetus infections
While MiaA itself may not become a direct diagnostic target due to its conservation across bacterial species, its downstream effects on protein expression patterns could yield valuable diagnostic markers for C. fetus detection and subspecies differentiation.
The relationship between MiaA and antimicrobial resistance in C. fetus represents an emerging area of research with several important dimensions:
Translational Control of Resistance Genes:
MiaA's role in tRNA modification affects translational fidelity, which could influence the expression of antimicrobial resistance genes.
Codon bias in resistance genes might make their translation particularly dependent on MiaA-modified tRNAs.
Changes in MiaA activity under antibiotic stress could alter the translation efficiency of resistance proteins.
Genomic Evidence and Resistance Genes:
Whole genome sequencing of C. fetus strains has identified antimicrobial resistance-related genes, including those encoding multidrug efflux pumps CmeABC and YkkCD .
Interestingly, research indicates that the presence of these genes alone is not sufficient to confer in vitro antimicrobial resistance .
This suggests that regulatory factors like MiaA might play a role in determining whether resistance genes are effectively translated into functional proteins.
Stress Response Connection:
Experimental Observations:
In C. fetus subsp. venerealis isolates, no in vitro antimicrobial resistance was detected against tetracycline, penicillin, enrofloxacin, and streptomycin, despite the presence of resistance genes .
This discrepancy between genomic potential and phenotype could involve translational regulation mechanisms.
Research Approaches:
Compare the antimicrobial susceptibility profiles of wild-type and miaA mutant C. fetus strains
Analyze the translation efficiency of specific resistance genes in the presence and absence of functional MiaA
Investigate whether antibiotic exposure alters MiaA expression or activity
Examine whether complementation with miaA can restore resistance in certain contexts
While direct experimental evidence linking MiaA to antimicrobial resistance in C. fetus is limited in the current literature, the fundamental role of MiaA in translational control suggests it could be an important factor in the expression of resistance determinants, particularly under stress conditions that bacteria encounter during antibiotic exposure.
The evolution of the miaA gene across Campylobacter species provides valuable insights into its functional importance and adaptation:
Conservation and Essentiality:
The miaA gene is part of the core genome of Campylobacter species, suggesting its fundamental importance for bacterial viability and fitness.
The high conservation of miaA across different Campylobacter species, including C. fetus, C. jejuni, and C. coli, indicates strong selective pressure to maintain its function .
This conservation extends to the enzymatic function of MiaA as a tRNA dimethylallyltransferase (EC:2.5.1.75) .
Subspecies Comparisons:
Comparative genomic analyses have shown that despite the distinct host preferences and pathogenicity of C. fetus subspecies, the miaA gene is conserved between them .
In whole genome analyses, C. fetus subspecies show approximately 92% sequence identity, with most conserved genes (including miaA) maintaining their syntenic relationships .
This conservation across subspecies that diverged to occupy different ecological niches further emphasizes the essential nature of MiaA function.
Differential Regulation:
While the miaA gene itself is conserved, its regulation may differ between species and subspecies.
These regulatory differences could contribute to species-specific adaptations without requiring changes to the core enzymatic function.
Research suggests that bacteria can modulate MiaA levels in response to environmental conditions, providing a mechanism for adaptation without sequence changes .
Research Approaches:
Phylogenetic analysis of miaA sequences across Campylobacter species and related genera
Functional complementation studies to test whether miaA from one species can restore function in another species
Analysis of selection pressures on different domains of the MiaA protein
Investigation of species-specific regulatory elements controlling miaA expression
Broader Evolutionary Context:
The tRNA modification system involving MiaA is ancient and widespread across bacteria, reflecting its fundamental role in translational control.
Comparative analysis with more distantly related bacteria could reveal how C. fetus MiaA has adapted to specific niche requirements.
The conservation of miaA across Campylobacter species with diverse ecological niches and pathogenic potential suggests that its core function in tRNA modification is essential for bacterial fitness across different environments, while potentially subtle variations in sequence or regulation may contribute to species-specific adaptations.
Investigating functional differences between MiaA enzymes from C. fetus subspecies fetus and venerealis requires careful comparative analysis:
While the search results do not provide direct experimental comparisons of MiaA function between the two subspecies, the fundamental importance of this enzyme combined with the distinct ecological niches of the subspecies suggests there may be subtle but important functional differences that contribute to their host adaptation and pathogenicity.